Literature DB >> 27168826

Characteristics of CD4+CD25+Foxp3+ regulatory T cells in patients with multiple organ dysfunction syndrome.

Xiuxian Zang1, Yanfang Jiang1, Xiujiang Li1, Yujun DU1, Junqi Niu1.   

Abstract

Multiple organ dysfunction syndrome (MODS) is a systemic inflammation. The aim of the present study was to evaluate the role of CD4+CD25+Foxp3+ regulatory T cells (Treg) in patients with MODS and to determine the association between Treg cells and serum cytokine levels. The percentage of Treg in 42 MODS patients and 10 healthy subjects was evaluated using flow cytometry. Serum levels of cytokines were measured using an enzyme-linked immunosorbent assay. The percentage of Treg cells was significantly elevated in patients with MODS on Day 1 (P<0.05). At Day 7, the percentage of Treg cells in MODS patients was reduced, but remained higher in comparison with the control group (P<0.05). The CD4+/CD8+ ratio and the levels of tumor necrosis factor-α (TNF-α), interleukin (IL)-2, IL-4, IL-6, IL-8, IL-10 and IL-1β were significantly enhanced in patients with MODS by Day 1. TNF-α, IL-2, IL-4 and IL-10 levels were gradually reduced to normal by Day 7, whereas the IL-6, IL-8 and IL-1β levels remained higher compared with the healthy subjects (P<0.001). The present results demonstrated an elevated percentage of CD4+CD25+Foxp3+ Treg cells in patients with MODS. Therefore, the proinflammatory cytokines TNF-α, IL-2, IL-6, IL-8 may promote MODS development, whereas the anti-inflammatory cytokines IL-4 and IL-10 may protect against MODS.

Entities:  

Keywords:  CD4+CD25+Foxp3+ regulatory T cells; cytokine/chemokine; multiple organ dysfunction syndrome

Year:  2016        PMID: 27168826      PMCID: PMC4840730          DOI: 10.3892/etm.2016.3157

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  22 in total

Review 1.  Regulatory T cells in autoimmmunity*.

Authors:  E M Shevach
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  Regulation of tumour immunity by CD25+ T cells.

Authors:  Awen Gallimore; Shimon Sakaguchi
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

Review 3.  FOXP3: not just for regulatory T cells anymore.

Authors:  Steven F Ziegler
Journal:  Eur J Immunol       Date:  2007-01       Impact factor: 5.532

4.  The CD4+/CD8+ ratio as a prognostic factor in patients with metastatic melanoma receiving chemoimmunotherapy.

Authors:  M Hernberg; T Muhonen; J P Turunen; M Hahka-Kemppinen; S Pyrhönen
Journal:  J Clin Oncol       Date:  1996-05       Impact factor: 44.544

5.  Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells.

Authors:  Christian Mottet; Holm H Uhlig; Fiona Powrie
Journal:  J Immunol       Date:  2003-04-15       Impact factor: 5.422

6.  Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis.

Authors:  Duojia Cao; Vivianne Malmström; Clare Baecher-Allan; David Hafler; Lars Klareskog; Christina Trollmo
Journal:  Eur J Immunol       Date:  2003-01       Impact factor: 5.532

Review 7.  [Cytokine storm in the pathogenesis of multiple organ dysfunction syndrome associated with surgical insults].

Authors:  N Aikawa
Journal:  Nihon Geka Gakkai Zasshi       Date:  1996-09

Review 8.  Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome.

Authors:  J C Marshall; D J Cook; N V Christou; G R Bernard; C L Sprung; W J Sibbald
Journal:  Crit Care Med       Date:  1995-10       Impact factor: 7.598

9.  Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.

Authors:  E Abraham; R Wunderink; H Silverman; T M Perl; S Nasraway; H Levy; R Bone; R P Wenzel; R Balk; R Allred
Journal:  JAMA       Date:  1995 Mar 22-29       Impact factor: 56.272

10.  CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells.

Authors:  Weihong Liu; Amy L Putnam; Zhou Xu-Yu; Gregory L Szot; Michael R Lee; Shirley Zhu; Peter A Gottlieb; Philipp Kapranov; Thomas R Gingeras; Barbara Fazekas de St Groth; Carol Clayberger; David M Soper; Steven F Ziegler; Jeffrey A Bluestone
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.